@article{jessop_manufacturing_2013,
	title = {Manufacturing misery in vaccines},
	volume = {25},
	issn = {0164-6826},
	url = {http://www.pharmtech.com/pharmtech/Manufacturing/Manufacturing-Misery-in-Vaccines/ArticleStandard/Article/detail/800848 http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=368461931},
	language = {English},
	number = {1},
	journal = {Pharmaceutical Technology Europe},
	author = {Jessop, N.},
	year = {2013},
	keywords = {*drug cost, *drug industry, *drug manufacture, *vaccine/pe [Pharmacoeconomics], *vaccine/pr [Pharmaceutics], Australia, Canada, Europe, France, Germany, Haemophilus influenzae, Italy, Singapore, Spain, Switzerland, authority, diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b hepatitis B vaccine/pe [Pharmacoeconomics], diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b hepatitis B vaccine/pr [Pharmaceutics], drug efficacy, drug safety, government, health care personnel, health insurance, hepatitis B, infection, influenza vaccine/pe [Pharmacoeconomics], influenza vaccine/pr [Pharmaceutics], poliomyelitis, short survey},
}

{"_id":"NZcNjWhv4ZZjxmmXd","bibbaseid":"jessop-manufacturingmiseryinvaccines-2013","authorIDs":[],"author_short":["Jessop, N."],"bibdata":{"bibtype":"article","type":"article","title":"Manufacturing misery in vaccines","volume":"25","issn":"0164-6826","url":"http://www.pharmtech.com/pharmtech/Manufacturing/Manufacturing-Misery-in-Vaccines/ArticleStandard/Article/detail/800848 http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=368461931","language":"English","number":"1","journal":"Pharmaceutical Technology Europe","author":[{"propositions":[],"lastnames":["Jessop"],"firstnames":["N."],"suffixes":[]}],"year":"2013","keywords":"*drug cost, *drug industry, *drug manufacture, *vaccine/pe [Pharmacoeconomics], *vaccine/pr [Pharmaceutics], Australia, Canada, Europe, France, Germany, Haemophilus influenzae, Italy, Singapore, Spain, Switzerland, authority, diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b hepatitis B vaccine/pe [Pharmacoeconomics], diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b hepatitis B vaccine/pr [Pharmaceutics], drug efficacy, drug safety, government, health care personnel, health insurance, hepatitis B, infection, influenza vaccine/pe [Pharmacoeconomics], influenza vaccine/pr [Pharmaceutics], poliomyelitis, short survey","bibtex":"@article{jessop_manufacturing_2013,\n\ttitle = {Manufacturing misery in vaccines},\n\tvolume = {25},\n\tissn = {0164-6826},\n\turl = {http://www.pharmtech.com/pharmtech/Manufacturing/Manufacturing-Misery-in-Vaccines/ArticleStandard/Article/detail/800848 http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=368461931},\n\tlanguage = {English},\n\tnumber = {1},\n\tjournal = {Pharmaceutical Technology Europe},\n\tauthor = {Jessop, N.},\n\tyear = {2013},\n\tkeywords = {*drug cost, *drug industry, *drug manufacture, *vaccine/pe [Pharmacoeconomics], *vaccine/pr [Pharmaceutics], Australia, Canada, Europe, France, Germany, Haemophilus influenzae, Italy, Singapore, Spain, Switzerland, authority, diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b hepatitis B vaccine/pe [Pharmacoeconomics], diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b hepatitis B vaccine/pr [Pharmaceutics], drug efficacy, drug safety, government, health care personnel, health insurance, hepatitis B, infection, influenza vaccine/pe [Pharmacoeconomics], influenza vaccine/pr [Pharmaceutics], poliomyelitis, short survey},\n}\n\n","author_short":["Jessop, N."],"key":"jessop_manufacturing_2013","id":"jessop_manufacturing_2013","bibbaseid":"jessop-manufacturingmiseryinvaccines-2013","role":"author","urls":{"Paper":"http://www.pharmtech.com/pharmtech/Manufacturing/Manufacturing-Misery-in-Vaccines/ArticleStandard/Article/detail/800848 http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=368461931"},"keyword":["*drug cost","*drug industry","*drug manufacture","*vaccine/pe [Pharmacoeconomics]","*vaccine/pr [Pharmaceutics]","Australia","Canada","Europe","France","Germany","Haemophilus influenzae","Italy","Singapore","Spain","Switzerland","authority","diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b hepatitis B vaccine/pe [Pharmacoeconomics]","diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b hepatitis B vaccine/pr [Pharmaceutics]","drug efficacy","drug safety","government","health care personnel","health insurance","hepatitis B","infection","influenza vaccine/pe [Pharmacoeconomics]","influenza vaccine/pr [Pharmaceutics]","poliomyelitis","short survey"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/zotero/vincentwntu","creationDate":"2020-01-26T03:06:33.952Z","downloads":0,"keywords":["*drug cost","*drug industry","*drug manufacture","*vaccine/pe [pharmacoeconomics]","*vaccine/pr [pharmaceutics]","australia","canada","europe","france","germany","haemophilus influenzae","italy","singapore","spain","switzerland","authority","diphtheria pertussis poliomyelitis tetanus haemophilus influenzae type b hepatitis b vaccine/pe [pharmacoeconomics]","diphtheria pertussis poliomyelitis tetanus haemophilus influenzae type b hepatitis b vaccine/pr [pharmaceutics]","drug efficacy","drug safety","government","health care personnel","health insurance","hepatitis b","infection","influenza vaccine/pe [pharmacoeconomics]","influenza vaccine/pr [pharmaceutics]","poliomyelitis","short survey"],"search_terms":["manufacturing","misery","vaccines","jessop"],"title":"Manufacturing misery in vaccines","year":2013,"dataSources":["icTw8KRRMMANXJHRd"]}